Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Antoniou, D. Hansell, M. Rubens, K. Marten, R. Tennant, T. Hansel, S. Desai, N. Siafakas, R. duBois, A. Wells (Heraklion, Greece; London, United Kingdom; Wuerzburg, Germany). Associations between emphysema and pulmonary fibrosis are suggestive of a smoking pathogenesis common to both disorders. Eur Respir J 2008; 32: Suppl. 52, 4223

Member's Comments

No comment yet.

Related content which might interest you: Cigarette smoking contributes to idiopathic pulmonary fibrosis associated with emphysema Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Pulmonary fibrosis is associated with emphysema in systemic sclerosis: indirect support for a smoking pathogenesis hypothesis Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Smoking is associated with more serious forms of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 543s Year: 2006 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Prevalence of active smokers among 49 patients affected by interstial lung diseases at two referral centers Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 The influence of smoking history on the prognosis of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006 Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study Source: Annual Congress 2007 - The air we breathe at home and at work Year: 2007 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Clinical determinants of exacerbations in severe, early-onset COPD Source: Eur Respir J 2007; 30: 1124-1130 Year: 2007 The prognostic importance of the protease-antiprotease imbalance in development of chronic obstructive pulmonary disease comorbid with chronic pancreatitis Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005 Relationship between nintedanib exposure and adverse events in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF treatment II Year: 2016